Literature DB >> 31226320

Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers.

Nicholas Teodoro1, Annie Fu1, N Tanya Ohly2, Noga Shalev3, Dara Matseoane-Peterssen1, Carolyn L Westhoff4.   

Abstract

OBJECTIVE(S): To describe differences in contraceptive knowledge, attitudes and use among HIV-infected and HIV-uninfected women served by an academic medical center in New York City and to describe gaps in knowledge and practice of gynecologic and HIV clinicians providing care at the same clinic sites where patients completed surveys. STUDY
DESIGN: We conducted a survey comparing contraceptive knowledge, attitudes, reproductive histories and long-acting reversible contraception (LARC) use in HIV-infected and -uninfected women. We also conducted a survey to elicit clinician demographic characteristics and education, contraceptive practice patterns and their knowledge of current contraceptive guidelines. We surveyed clinicians and patients at five ambulatory sites.
RESULTS: We screened 90% of patients approached. All 257 women who were eligible completed a survey. These included 107 (42%) HIV-infected women and 150 (58%) HIV-uninfected women. HIV-infected women were older, were more likely to be black/African-American, were less likely to be Latina, were more likely to receive public assistance and had lower educational attainment. HIV-infected women reported lower lifetime LARC use (12% vs. 28%) and higher recent condom use (58% vs. 25%) than HIV-uninfected women. Both groups reported similar attitudes toward intrauterine devices (IUDs) and implants. HIV clinicians were less likely to have had training in or discuss LARC methods with their patients.
CONCLUSIONS: HIV-infected women were less likely to be current (last 30 days) or ever LARC users, despite having similar attitudes toward IUDs and implants, compared to HIV-uninfected women. HIV providers had lower levels of knowledge of HIV-specific contraceptive guidelines compared with gynecology practitioners. IMPLICATIONS: HIV-infected women and their providers share a knowledge gap regarding LARC. Increased interdisciplinary collaboration may help mitigate the resulting disparities in access to highly effective contraception in HIV-infected women. Knowledge of HIV-specific contraceptive guidelines and ability to place contraceptive implants were low among all surveyed providers, suggesting need for additional training.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Contraception; Family planning; HIV; LARC; Women

Year:  2019        PMID: 31226320     DOI: 10.1016/j.contraception.2019.06.005

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

1.  Contraception methods used among women with HIV starting antiretroviral therapy in a large United States clinical trial, 2009-2011.

Authors:  Anandi N Sheth; Christine D Angert; Lisa B Haddad; C Christina Mehta; Susan E Cohn
Journal:  Contraception       Date:  2020-11-12       Impact factor: 3.375

2.  'I feel like a person has a right to use a product to protect themselves…': a qualitative study of the risk-benefit calculus on women's contraceptive use and choice.

Authors:  Sofía L Carbone; Melissa Guillen; Jaime J Ramirez; Sara E Vargas; Connie Fei Lu; Melissa L Getz; Yaa Frimpong; Kelley A Smith; Claire Stout; Iris Tong; Melanie Hill; Robert E Berry; Abigail Harrison; Kate M Guthrie
Journal:  Sex Health       Date:  2020-06       Impact factor: 2.706

3.  Low Rates of Contraception Use in Women With Human Immunodeficiency Virus.

Authors:  Manasa Bhatta; Aihua Bian; Jamison Norwood; Bryan E Shepherd; Imani Ransby; Jeffrey Nelson; Megan Turner; Timothy R Sterling; Jessica L Castilho
Journal:  Open Forum Infect Dis       Date:  2022-03-08       Impact factor: 3.835

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.